Background
Kidney transplantation has transformed the lives of individuals with end-stage renal disease, significantly improving their quality of life and, for women, restoring some degree of fertility. However, achieving pregnancy post-transplantation comes with unique challenges, particularly for those requiring assisted reproductive technology (ART). A recent study published in the journal Transplantation sheds light on the potential risks associated with ART in kidney transplant recipients.
Scientific and Clinical Evidence: What the Data Tell Us
The study, conducted by Silvi Shah, MD, and colleagues at the University of Cincinnati, analyzed data from the Transplant Pregnancy Registry International to explore pregnancy outcomes in kidney transplant recipients who utilized ART versus natural conception. This large retrospective cohort study spanned over three decades, from 1988 to 2022, and included women aged 14 and older who had undergone kidney transplantation.
Key findings revealed increased odds of complications among pregnancies conceived via ART compared to natural conception. Specifically, the odds ratios indicated heightened risks of hypertension (OR 1.57), cesarean delivery (OR 1.60), and preterm birth (OR 2.07). Additionally, infants born to ART pregnancies had a lower median birth weight of 2551 grams versus 2722 grams for natural conceptions. While rates of preeclampsia, gestational diabetes, miscarriage, and live births were comparable across groups, neonatal deaths were notably higher in the ART group (4.4% versus 0.8%).
Misconceptions and Harmful Behaviors
A common misconception among kidney transplant recipients is that ART might exacerbate graft loss or lead to worse long-term outcomes for both mother and child. However, the study found no significant differences in two-year graft survival rates between the ART and natural conception groups. This underscores that while certain risks are elevated, the overall feasibility of ART remains intact, provided specific clinical criteria are met.
Correct Health Practices and Practical Recommendations
For women with kidney transplants aspiring to conceive, proper pre-conception planning is critical. Specialists recommend ensuring stable kidney function, optimal creatinine levels, controlled blood pressure, and well-managed immunosuppression regimens. ART should be pursued under close medical supervision, with a multidisciplinary team including nephrologists, obstetricians, and reproductive endocrinologists.
Expert Insights and Commentary
Dr. Silvi Shah emphasized the importance of individualized care and informed decision-making for kidney transplant recipients. “Our findings serve as a guide for clinicians in counseling patients about family planning and the use of ART. While certain risks are higher, outcomes like long-term kidney function and live birth rates are not adversely impacted,” she stated.
Conclusion
The use of ART in kidney transplant recipients is associated with certain elevated pregnancy risks, particularly hypertension, preterm birth, and neonatal mortality. However, with adequate pre-conception planning and clinical oversight, ART remains a viable option for this population. The findings of this study empower clinicians and patients to make more informed reproductive choices, balancing the risks and benefits effectively.
References
1. University of Cincinnati study explores fertility treatment risks for kidney transplant recipients. University of Cincinnati. July 7, 2025. Accessed July 11, 2025.
https://www.eurekalert.org/news-releases/1090242
2. Shah S, Rachwal B, Vyas P, et al. Pregnancy outcomes using assisted reproductive technology in kidney transplant recipients. Transplantation. 2025. doi:10.1097/TP.0000000000005449